WARSAW, Ind., December 16, 2025 — Zimmer Biomet Holdings, Inc., a global leader in medical technology, has entered into an exclusive collaboration with OneStep, an FDA-listed digital mobility intelligence platform, to enhance recovery monitoring following joint replacement surgery. The partnership integrates OneStep’s clinically validated gait and mobility analytics into Zimmer Biomet’s mymobility® Care Management Platform, enabling surgeons and patients to access objective, real-world mobility data through everyday smartphones. The initiative reflects the accelerating convergence of orthopedic devices, digital health, and data-driven care across the surgical continuum.
Science Significance
From a scientific perspective, the collaboration advances the concept of mobility as a measurable digital biomarker. By embedding continuous gait and functional mobility analytics into post-operative care, the platform moves beyond episodic clinical assessments to deliver longitudinal, real-world evidence on how patients actually move in daily life. OneStep’s technology analyzes more than one million gait cycles per day, creating one of the largest mobility datasets globally. This depth of data allows clinicians to quantify functional recovery, detect deviations earlier, and correlate mobility trends with clinical outcomes, strengthening evidence-based orthopedic care.
Regulatory Significance
The integration carries meaningful regulatory relevance, as it combines FDA-listed digital health technology with a widely deployed care management platform used in orthopedic recovery. Such solutions must operate within medical device quality systems, software lifecycle controls, and data integrity expectations consistent with regulated healthcare environments. The collaboration highlights how digitally enabled MedTech solutions are evolving within established compliance frameworks, supporting safe, validated, and scalable use of real-world mobility data without adding operational burden for clinicians or patients.
Business Significance
Advertisement
Strategically, the collaboration reinforces Zimmer Biomet’s connected care strategy, extending its portfolio beyond implants into integrated digital and data-driven services. As value-based care models increasingly reward functional outcomes, the ability to deliver objective recovery metrics becomes a differentiator for MedTech leaders. For OneStep, integration into a global platform like mymobility expands commercial reach and embeds its analytics into routine orthopedic workflows. Together, the companies strengthen their positions in a rapidly growing market for digital orthopedic solutions and post-acute care analytics.
Patients’ Significance
For patients undergoing joint replacement, the collaboration translates into a more transparent, engaging, and personalized recovery experience. Through smartphone-based monitoring, patients gain daily insights into their mobility progress, empowering them to take an active role in rehabilitation. Continuous feedback helps patients understand recovery milestones, while clinicians can intervene earlier when progress stalls. By reducing reliance on subjective reporting alone, the solution supports more confident recovery journeys, potentially improving satisfaction, adherence to rehabilitation plans, and overall outcomes.
Policy Significance
At a policy level, the collaboration aligns with broader healthcare priorities emphasizing digital transformation, remote monitoring, and outcomes-based care. As healthcare systems seek to manage rising surgical volumes and workforce constraints, scalable digital tools that enable remote assessment of recovery are increasingly valued. The use of smartphone-enabled mobility intelligence supports policies promoting accessibility, equity, and efficient use of healthcare resources, while contributing to the growing body of real-world data that can inform future orthopedic care standards.
The Zimmer Biomet–OneStep collaboration underscores how MedTech innovation is reshaping orthopedic recovery by combining implants, digital platforms, and clinically validated analytics into a unified ecosystem. By transforming gait and mobility into actionable clinical data, the partnership exemplifies the next phase of connected care—one that is measurable, patient-centered, and data-driven. As adoption of such technologies expands, digitally enabled mobility intelligence is poised to become a foundational element of modern orthopedic practice.
Source: Zimmer Biomet Holdings, Inc. press release
